Daily non-political popular news in brief.

A new way of classifying addictive drugs

Although addictive drugs have diverse molecular targets in the brain, they share the common initial effect of increasing the concentration of a substance called dopamine. In an article in PLoS Medicine, researchers Christian Lüscher (University of Geneva) and Mark A. Ungless (Imperial College London) review recent research that has advanced our understanding of the molecular mechanisms underlying this increase of dopamine. Based on this research, they propose a new classification for addictive drugs.

Read more »

Keywords: way, classifying, addictive, drugs, drug

« Previous | Next »

Similar news on "A new way of classifying addictive drugs":

1. Cell skeleton may hold key to overcoming drug resistance in cancer
   10-03-2007 · EurekAlert!
   Researchers have uncovered a new way in which a cell protein protects cancer cellsfrom a wide range of chemotherapeutic drugs, identifying a possible target forimproving treatment outcomes for patients.
   Similar news · Read more »
   
2. Assembling the jigsaw puzzle of drug addiction
   01-04-2008 · EurekAlert!
   Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs. This novel paper appears in PLoS Computational Biology on Jan. 4, 2008.
   Similar news · Read more »
   
3. Does a component of niacin point the way to anti-aging drugs?
   02-08-2007 · EurekAlert!
   In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms and flies. A number of scientific groups and biotechnology companies are eagerly searching for drug candidates able to boost sirtuin activity, hoping to develop an "anti-aging" drug. Now, a new study from scientists at the Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers.
   Similar news · Read more »
   
4. Tequila raw ingredient being developed into drug-carrier that targets colon diseases
   03-27-2007 · EurekAlert!
   Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
   Similar news · Read more »
   
5. Taste test may identify best drugs for depression
   12-05-2006 · EurekAlert!
   New research has shown that it might be possible to use taste as an indicator as to whether someone is depressed, and as a way of determining which is the most suitable drug to treat their depression. Different antidepressants work better in some people than others.
   Similar news · Read more »
   
6. New chemistry approach promises less expensive drugs
   03-29-2007 · EurekAlert!
   With a newly discovered method of assembling organic molecules, chemists may have found a way to sidestep many of the expensive and hazardous barriers that stand in the way of drug development. The new approach allows scientists to synthesize molecules without employing toxic catalysts, and it also does not generate alternate versions of drug molecules that can damage the body, two perennial issues that plague the manufacturing process.
   Similar news · Read more »
   
7. MIT: 'Micro' livers could aid drug screening
   11-18-2007 · EurekAlert!
   MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could allow better screening of new drugs that are potentially harmful to the liver and reduce the costs associated with their development.
   Similar news · Read more »
   
8. Plant pathogen yields substance to fight neuroblastoma
   01-17-2008 · EurekAlert!
   Drug treatment of neuroblastoma, a tumor of the nervous system in children, poses major problems. Therefore, scientists at the German Cancer Research Center have been searching for substances that are suitable as a basis for developing better drugs. Now they have found a candidate: HC-toxin, which is isolated from a fungal plant pathogen. The substance from the maize pathogen reprograms neuroblastoma cells in such a way that they behave almost like healthy cells again.
   Similar news · Read more »
   
9. Mechanism of nicotine's learning effects explored
   04-04-2007 · EurekAlert!
   While nicotine is highly addictive, researchers have also shown the drug to enhance learning and memory -- a property that has launched efforts to develop nicotine-like drugs to treat cognitive deficits in Alzheimer's and Parkinson's diseases, schizophrenia and attention-deficit/hyperactivity disorder.
   Similar news · Read more »
   
10. Discovery of an HIV inhibitor in human blood points to new drug class
    04-19-2007 · EurekAlert!
    A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
    Similar news · Read more »